Biocon Biologics Uk Ltd
Clinical trials sponsored by Biocon Biologics Uk Ltd, explained in plain language.
-
New psoriasis drug shows promise in Head-to-Head trial against stelara
Disease control CompletedThis study tested whether a new drug called Bmab 1200 works as well as the approved drug Stelara for adults with moderate to severe plaque psoriasis. 384 participants received either Bmab 1200 or Stelara, and researchers measured skin clearance using the Psoriasis Area and Severi…
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
New osteoporosis drug shows promise in Head-to-Head trial
Disease control CompletedThis study tested a new drug called Bmab 1000 against the approved drug Prolia in 479 postmenopausal women with osteoporosis. The goal was to see if Bmab 1000 works as well as Prolia at improving bone density and reducing bone breakdown. Participants received either Bmab 1000 or …
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated May 18, 2026 12:04 UTC